Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
BMC Medical Imaging|November 14, 2023
High throughput method for detecting murine brain atrophy using a clinical 3T MRIMichael Linzey, Krista DiSano, Nora Welsh, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2012
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 responseFrancesca Gilli, Nicole D Navone, Paola Valentino, et al.Journal of Neurology|December 15, 2010
One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patientsSimona Malucchi, Francesca Gilli, Marzia Caldano, et al.Journal of Immunological Methods|October 28, 2009
Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon betaMiranda M C van Beers, Melody Sauerborn, Francesca Gilli, et al.Electrophoresis|August 18, 2010
Acute-phase proteins investigation based on lectins affinity capture prior to 2-DE separation: application to serum from multiple sclerosis patientsAndrea Robotti, Massimo Natale, Alessandra Giuliano Albo, et al.Archives of Neurology|March 16, 2011
Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosisFrancesca Gilli, Nicole Désirée Navone, Simona Perga, et al.Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|March 18, 2005
Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosisFrancesca Gilli, Fabiana Marnetto, Guglielmo Stefanuto, et al.Journal of Neuroimmunology|October 24, 2009
Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis OpticaFabiana Marnetto, Bianca Hellias, Letizia Granieri, et al.Brain, Behavior, and Immunity|March 5, 2026
Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosisMichael Linzey, Steven C Pike, Nour-Maria Bouzid, et al.Archives of Neurology|February 10, 2010
Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosisLaura F van der Voort, Francesca Gilli, Antonio Bertolotto, et al.Pageof 9